SCHEMBL22887993

SCHEMBL22887993

CCOC(O)c1ncn2cnc(C(F)(F)F)cc12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18366439 0.70 MAPT (0.40) —
SCHEMBL21033478 0.65 PDE10A (0.33) PDE4B
SCHEMBL18365963 0.63 ASPH (0.33) —
SCHEMBL30587606 0.62 ALDH1A1 (0.38) —
SCHEMBL20356642 0.61 PKM (0.42) —
SCHEMBL28759933 0.60 CA2 (0.42) —
SCHEMBL22056199 0.58 EGLN2 (0.36) —
SCHEMBL18189827 0.57 GRIA1 (0.51) —
SCHEMBL11784400 0.57 ALDH1A1 (0.39) PDE4B
SCHEMBL25153650 0.57 ALDH1A1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 — — EP disclosed
Send feedback